PROMACTA (eltrombopag) Patient Assistance Program
Don’t let the high cost of brand specialty thrombopoietin receptor agonist therapy disrupt your treatment. We help eligible patients access Promacta (eltrombopag) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Promacta (eltrombopag) is FDA-approved for chronic immune thrombocytopenia (ITP) in adults and pediatric patients (≥1 year) with inadequate response to corticosteroids, immunoglobulins, or splenectomy; for severe aplastic anemia in patients (≥2 years) with insufficient response to immunosuppressive therapy; for newly diagnosed severe aplastic anemia (in combination with standard immunosuppressive therapy); and for thrombocytopenia in adults with chronic hepatitis C to enable initiation and maintenance of interferon-based therapy.
- Without assistance, Promacta costs commonly run approximately $7,000–$9,000 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Promacta for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Promacta in the U.S. as of 2026. Other thrombopoietin receptor agonists include romiplostim (Nplate, SC weekly), avatrombopag (Doptelet, oral), and lusutrombopag (Mulpleta, oral for periprocedural use). Each has different indications and dosing.
What Is Promacta Prescription Assistance Program?
The Promacta Prescription Assistance Program is a manufacturer-sponsored initiative that provides Promacta at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for ITP, aplastic anemia, and chronic hepatitis C patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, hematology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, Promacta costs roughly $7,000–$9,000/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$8,500 | Save ~$8,430/mo |
| CVS Pharmacy | ~$9,000 | Save ~$8,930/mo |
| Walmart | ~$7,500 | Save ~$7,430/mo |
| Costco | ~$7,300 | Save ~$7,230/mo |
Specialty Pharmacy | ~$8,000 | Save ~$7,930/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Promacta Prescription Program?
The Patient Assistance Program is free to apply for and provides Promacta at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Promacta:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $7,000–$9,000 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Promacta assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Promacta Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Promacta:
Promacta (eltrombopag) is a once-daily oral non-peptide thrombopoietin receptor agonist used to stimulate platelet production in chronic ITP, severe aplastic anemia, and thrombocytopenia in chronic hepatitis C. It mimics the action of thrombopoietin (TPO) — the body’s main regulator of platelet production.
How Promacta Works:
Eltrombopag is an oral medication that binds to the transmembrane site of thrombopoietin (TPO) receptors on megakaryocyte precursors and stem cells. By mimicking TPO, it stimulates signaling pathways that drive platelet production to counteract the destruction seen in chronic ITP. In aplastic anemia, it also stimulates hematopoietic stem cells, which helps recover red and white blood cells alongside platelets. This mechanism differs from romiplostim, which is a peptide TPO agonist administered via subcutaneous injection.
Form and use:
Promacta is an oral tablet taken once daily on an empty stomach, either 2 hours before or 4 hours after a meal. It must be spaced at least 4 hours apart from dairy, antacids, or supplements containing polyvalent cations like calcium, iron, or magnesium. Dosing is highly individualized, usually starting at 50 mg once daily, though a lower starting dose is required for Asian patients or those with hepatic impairment. Doctors then titrate the dosage over time based on the patient’s specific platelet response.
Generic availability:
As of 2026, there is no generic version of Promacta available in the United States. Patients looking for alternatives within the same drug class can consider other TPO receptor agonists like romiplostim, avatrombopag, or lusutrombopag. Some of these alternatives are oral, while others are administered via weekly subcutaneous injections. The final choice among these medications depends on the patient’s specific medical indication, dosing preference, and clinical factors.
Warnings:
Promacta carries significant warnings for hepatotoxicity, requiring regular liver function tests before starting and throughout treatment. It increases the risk of cataracts, requiring periodic eye exams, as well as thromboembolic events like portal vein thrombosis. The drug is contraindicated in certain chronic hepatitis C patients due to hepatic decompensation risks and should be avoided in MDS due to the risk of progression to AML. Additionally, patients face a risk of recurrent thrombocytopenia once they discontinue the medication.
FAQ (Frequently Asked Questions)
How Much Does Promacta Cost Without Insurance?
Promacta costs approximately $7,000–$9,000 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Promacta at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Do I Need To Take Promacta On An Empty Stomach Away From Food And Supplements?
Polyvalent cations (calcium, iron, magnesium, aluminum, zinc, selenium) bind eltrombopag in the gut and dramatically reduce absorption — sometimes by 70% or more. Take Promacta at least 2 hours before or 4 hours after meals, dairy, antacids, calcium-fortified foods/juices, and mineral supplements. This is the most important dosing requirement — getting it wrong can make Promacta ineffective.
How Is Promacta Different From Nplate?
Both are TPO receptor agonists for ITP. Promacta (eltrombopag) is an oral once-daily pill but requires strict empty-stomach dosing away from food and cations. Nplate (romiplostim) is a once-weekly subcutaneous injection given by a healthcare provider (or self-administered after training) — no food restrictions. Choice depends on whether you prefer oral with strict dosing rules or weekly injection.
How Long Until Promacta Works?
Platelet counts typically begin to rise within 1–2 weeks of starting Promacta. Peak effect is usually at 2–3 weeks. Dose is then individualized based on platelet response (target: platelet count adequate to reduce bleeding risk, typically ≥50 × 10⁹/L, while avoiding excessive counts). Some patients respond to lower doses; others need higher doses.
Why Do I Need Eye Exams On Promacta?
Cataracts (lens opacities) have been reported with eltrombopag. Baseline eye exam and periodic monitoring during therapy are recommended. Tell your hematologist about vision changes.
Can I Get Promacta Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — switching to another TPO agonist with its own PAP (Nplate, Doptelet), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Platelet Disorder Support Association, Aplastic Anemia and MDS International Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Promacta, our team may be able to help you access assistance programs designed to make brand specialty thrombopoietin receptor agonist therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.